Navigation Links
Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
Date:4/23/2008

BETHESDA, Md., April 23 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, announced the start of a phase 1 clinical trial with its BiTE(R) antibody MT110. The study will explore the safety, pharmacokinetics, pharmacodynamics and anti-tumor activity of MT110 in patients with lung and gastrointestinal cancers.

MT110 targets the epithelial cell adhesion molecule (EpCAM or CD326), which is highly expressed on colon, lung, breast, prostate, ovarian, gastric and pancreas cancers. Additionally, EpCAM has been found on cancer stem cells of colon, breast, prostate and pancreas cancers. Cancer stem cells are believed to cause metastases and recurrence of these cancers. MT110 is the second BiTE antibody in clinical trials, and the fourth clinical program in Micromet's product pipeline. The first BiTE antibody, MT103 (MEDI-538), is now in phase 1 and phase 2 clinical trials for the treatment of haematological cancers.

"BiTE antibodies enable the patients' own T cells to very efficiently eliminate tumor cells," comments Patrick Baeuerle, Chief Scientific Officer of Micromet, "In various experimental tumor models, we have demonstrated the high therapeutic potential of EpCAM-specific BiTE antibodies, and we are now looking forward to determining the safety and the therapeutic potential of MT110 in patients."

"Having obtained clinical proof of concept for our BiTE antibody technology with MT103 in haematological cancers, we are excited about exploring the potential of MT110 in treating solid tumors," comments Carsten Reinhardt, Chief Medical Officer of Micromet. "Based on its unique mode of ac
'/>"/>

SOURCE Micromet, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study
2. Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma
3. Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies
4. Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research
5. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
6. Micromet Announces Changes in Management Team
7. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
8. VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
9. Spectranetics Enrolls First Patient in PATENT Trial for the Treatment of Instent Restenosis
10. Human Genome Sciences Completes Enrollment in First of Two Phase 3 Lymphostat-B(R) Trials
11. Edwards Lifesciences Announces First Implants in U.S. Study of Minimally-Invasive Pulmonic Valve
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... May 1, 2015   Heska Corporation (NASDAQ: ... a provider of advanced veterinary diagnostic and other specialty ... Executive Chair, will present at the 16th Annual B. Riley ... 13, 2015. The conference will be held May 12-14, 2015 ... Heska management will be available during the day on ...
(Date:5/1/2015)... , May 1, 2015 Braeburn ... its current therapeutic focus beyond addiction and ... psychiatric disorders. Braeburn has acquired an implantable, ... antipsychotic risperidone for treatment of schizophrenia from ... acquires global rights to other potential applications ...
(Date:5/1/2015)...  Boston Scientific Corporation (NYSE: BSX ) is ... long-term growth strategies at a meeting with the investment ... . President and Chief Executive Officer Mike Mahoney ... to bring forward meaningful innovation to transform patient care, ... value. "We are focused on addressing ...
Breaking Medicine Technology:Heska to Present at the 16th Annual B. Riley & Co. Investor Conference 2Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 2Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 3Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 4Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 2Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 3Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 4Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 5Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 6Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 7
... LYNDHURST, N.J., Aug. 30 A molecular,diagnostic ... 85,developmental disorders affecting children now is commercially ... testing and,reimbursement by leading health plans across ... ), the nation,s leading provider of diagnostic,testing, ...
... Cadence Pharmaceuticals,Inc. (Nasdaq: CADX ), ... commercializing proprietary product candidates principally,for use in ... completed patient,enrollment in a pivotal Phase III ... intravenous acetaminophen (IV,acetaminophen), for the treatment of ...
Cached Medicine Technology:Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children 2Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children 3Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children 4Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule 2Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule 3Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule 4Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule 5
(Date:5/2/2015)... Peachtree Audio ” was featured on NewsWatch as part ... and coolest technology products available to consumers. Scott Steinberg, ... the review and shared with viewers how this is ... important part of people’s lives – and as such, ... Peachtree Audio does just that with high-end audio equipment ...
(Date:5/2/2015)... Kare Visits LLC. launched in Chicago in response ... Kare Visits offers relief for caregivers by visiting loved ones ... According to the Caregiver Action Network, eight in ten caregivers ... a week caring for an elderly or disabled loved one. ... nurse, a caregiver is now empowered to schedule an on ...
(Date:5/2/2015)... ZoomCare, the Portland-based innovator of on-demand healthcare ... its new healthcare insurance to individuals and small businesses ... System is the nation’s first health insurance system built ... Personal Health Insurance was ZoomCare’s first such filing including ... to review and regulation by the Oregon Insurance Division. ...
(Date:5/1/2015)... IDLife LLC, a health and wellness company headquartered ... of its newest partner and fitness celebrity, Jen Widerstrom. ... up in gymnastics and competitive diving, but truly found ... trainer and helping others achieve their fitness aspirations. Jen ... highlighting her stunning physique and unique training techniques. ...
(Date:5/1/2015)... Pioneer Millworks, the largest reclaimed wood company in ... wood products at the 27th annual International Contemporary Furniture ... this May. Their newest offerings, Vat 35, Mushroom Boards, ... color to North America's platform for global design. ... in the design world and we're excited to share ...
Breaking Medicine News(10 mins):Health News:Affordable High-End Audio Equipment was Featured on NewsWatch Television 2Health News:Chicagoan Seeks to Transform Industry by Launching an Innovative Elderly Care Solution 2Health News:ZoomCare Applies to be on Oregon Exchange 2Health News:IDLife LLC Announces New Partnership with Fitness Celebrity, Jen Widerstrom 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3
... ... for many people with knee joint arthritis according to The Stone Research Foundation. These ... , ... CA (PRWEB) March 22, 2010 -- Biologic Joint Reconstruction, rather than bionic (artificial) replacement, ...
... ... Join Not-For-Profit Catholic Health System Board, , ... Novi, Michigan (Vocus) March 23, 2010 -- Trinity Health ... Directors. The new members are Paul Robertson, Chairman and CEO of Robertson Brothers Company ...
... of paintings shows bigger helpings over time, researchers say ... Supper" might serve as an early warning sign of ... paintings of Christ,s final meal have shown increasingly larger ... depiction shows that people have slowly been increasing their ...
... last that replacing saturated fats has heart benefits ... fats with polyunsaturated fats may reduce your risk of ... Public Health researchers reviewed eight studies with a total ... saturated fats in their diet with polyunsaturated fats had ...
... its impact on the insured, the uninsured, young adults, seniors ... the historic passage of health care reform legislation by the ... law by President Barack Obama two days later, many Americans ... new legislation expands coverage to the uninsured of course, but ...
... ... and chronic conditions affecting soft tissues, such as tendons and ligaments. , ... New York (PRWEB) March 23, ... medicine and rehabilitation services in the metropolitan New York area, is pleased to announce ...
Cached Medicine News:Health News:Biologic Joint Reconstruction Using Stem Cells Proven Successful In Patients With Arthritis 2Health News:Biologic Joint Reconstruction Using Stem Cells Proven Successful In Patients With Arthritis 3Health News:Biologic Joint Reconstruction Using Stem Cells Proven Successful In Patients With Arthritis 4Health News:Biologic Joint Reconstruction Using Stem Cells Proven Successful In Patients With Arthritis 5Health News:Trinity Health Appoints Four to Board of Directors,Trinity Health Appoints Four to Board of Directors, 2Health News:Trinity Health Appoints Four to Board of Directors,Trinity Health Appoints Four to Board of Directors, 3Health News:Even in 'Last Supper,' Portion Sizes Have Grown 2Health News:Polyunsaturated Fats Really May Lower Heart Risk 2Health News:Health Care Reform: How You Will Fare 2Health News:Health Care Reform: How You Will Fare 3Health News:Health Care Reform: How You Will Fare 4Health News:New York Sports Medicine Offers Platelet Rich Plasma Therapy For Treatment of Injury 2Health News:New York Sports Medicine Offers Platelet Rich Plasma Therapy For Treatment of Injury 3
Round serrated handle, dull finish....
Cross action, round handle, maximum opening 2.8 mm....
Cross action, round handle, maximum opening 2.8 mm....
Cross action, round handle, maximum opening 2.8 mm....
Medicine Products: